文献速递乳腺介入MRUS

影像引导乳腺病灶微创经皮治疗:现状与展望

Image-guided Microinvasive Percutaneous Treatment of Breast Lesions: Where Do We Stand?
PubMed 文献 · Radiographics · 2021-01-01

本文综述了乳腺病灶微创经皮治疗技术,包括冷冻消融、射频消融、微波消融、高强度聚焦超声、激光治疗、真空辅助切除和不可逆电穿孔。目前仅冷冻消融和真空辅助切除获美国FDA批准用于治疗纤维腺瘤,并被美国乳腺外科医师协会纳入治疗路径。MRI是术后随访最有效的影像方法,增强模式可鉴别残留或复发与术后改变。

要点

  • 冷冻消融和真空辅助切除已获FDA批准用于纤维腺瘤治疗。
  • MRI增强模式可鉴别术后残留或复发与术后改变,是随访首选。
  • 射频消融和冷冻消融在早期乳腺癌治疗中数据较多,结果有前景。

核心结论

  • 乳腺病灶治疗趋向微创,冷冻消融和真空辅助切除已获FDA批准用于纤维腺瘤并纳入美国乳腺外科医师协会治疗路径。
  • 早期乳腺癌的微创治疗研究结果有前景,射频消融和冷冻消融的数据多于其他方法。
  • 临床决策应基于技术可及性个体化制定,MRI是术后随访最有效的影像方法。

研究设计与样本

  • 综述性文章,检索范围与纳入文献未在摘要中报告。

关键影像表现/征象

  • 原文未涉及具体影像征象。

诊断标准与关键数值

  • 原文未报告敏感度、特异度、AUC、阈值或分级标准。

临床应用与阅片要点

  • MRI增强模式可用于鉴别术后残留或复发与术后改变。
  • 临床决策应基于技术可及性个体化制定。
  • 冷冻消融和真空辅助切除已获FDA批准用于纤维腺瘤。

局限性

  • 原文为综述,未报告系统检索策略与纳入文献特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Treatment of breast lesions has evolved toward the use of less-invasive or minimally invasive techniques. Minimally invasive treatments destroy focal groups of cells without surgery; hence, less anesthesia is required, better cosmetic outcomes are achieved because of minimal (if any) scarring, and recovery times are shorter. These techniques include cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused US, laser therapy, vacuum-assisted excision, and irreversible electroporation. Each modality involves the use of different mechanisms and requires specific considerations for application. To date, only cryoablation and vacuum-assisted excision have received U.S. Food and Drug Administration approval for treatment of fibroadenomas and have been implemented as part of the treatment algorithm by the American Society of Breast Surgeons. Several clinical studies on this topic have been performed on outcomes in patients with breast cancer who were treated with these techniques. The results are promising, with more data for radiofrequency ablation and cryoablation available than for other minimally invasive methods for treatment of early-stage breast cancer. Clinical decisions should be made on a case-by-case basis, according to the availability of the technique. MRI is the most effective imaging modality for postprocedural follow-up, with the pattern of enhancement differentiating residual or recurrent disease from postprocedural changes. ©RSNA, 2021.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Roknsharifi S, Wattamwar K, Fishman MDC, et al. Image-guided Microinvasive Percutaneous Treatment of Breast Lesions: Where Do We Stand? Radiographics. 2021. PMID: 34197250. doi:10.1148/rg.2021200156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。